Edgewell Personal Care CompanyEPCNYSE
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average, slight contraction.
Left:
||||
Year-over-year research & development expense growth
Latest
12.86%
↑ 32% above average
Average (39q)
9.78%
Historical baseline
Range
High:370.59%
Low:-24.88%
CAGR
-8.3%
Structural decline
| Period | Value |
|---|---|
| Q3 2025 | 12.86% |
| Q2 2025 | 0.72% |
| Q1 2025 | 0.00% |
| Q4 2024 | -14.72% |
| Q3 2024 | 11.64% |
| Q2 2024 | 2.82% |
| Q1 2024 | 6.77% |
| Q4 2023 | -16.35% |
| Q3 2023 | 7.43% |
| Q2 2023 | 2.78% |
| Q1 2023 | 7.46% |
| Q4 2022 | -12.99% |
| Q3 2022 | 13.24% |
| Q2 2022 | -0.73% |
| Q1 2022 | 7.03% |
| Q4 2021 | -15.79% |
| Q3 2021 | 4.11% |
| Q2 2021 | 2.10% |
| Q1 2021 | 4.38% |
| Q4 2020 | -9.87% |
| Q3 2020 | 22.58% |
| Q2 2020 | -10.79% |
| Q1 2020 | 0.72% |
| Q4 2019 | -1.43% |
| Q3 2019 | 8.53% |
| Q2 2019 | -7.86% |
| Q1 2019 | 11.11% |
| Q4 2018 | -13.70% |
| Q3 2018 | -2.01% |
| Q2 2018 | -3.87% |
| Q1 2018 | -3.73% |
| Q4 2017 | -7.47% |
| Q3 2017 | 6.10% |
| Q2 2017 | -6.29% |
| Q1 2017 | 7.36% |
| Q4 2016 | -24.88% |
| Q3 2016 | 24.00% |
| Q2 2016 | 4.79% |
| Q1 2016 | 4.38% |
| Q4 2015 | 370.59% |